150 related articles for article (PubMed ID: 15040828)
1. BMD is reduced in HIV-infected men irrespective of treatment.
Amiel C; Ostertag A; Slama L; Baudoin C; N'Guyen T; Lajeunie E; Neit-Ngeilh L; Rozenbaum W; De Vernejoul MC
J Bone Miner Res; 2004 Mar; 19(3):402-9. PubMed ID: 15040828
[TBL] [Abstract][Full Text] [Related]
2. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
Madeddu G; Spanu A; Solinas P; Calia GM; Lovigu C; Chessa F; Mannazzu M; Falchi A; Mura MS; Madeddu G
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003
[TBL] [Abstract][Full Text] [Related]
3. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
[TBL] [Abstract][Full Text] [Related]
4. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
7. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].
Schnabel M; Eser G; Ziller V; Mann D; Mann E; Hadji P
Zentralbl Chir; 2005 Oct; 130(5):469-75. PubMed ID: 16220445
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
[TBL] [Abstract][Full Text] [Related]
9. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.
Duvivier C; Kolta S; Assoumou L; Ghosn J; Rozenberg S; Murphy RL; Katlama C; Costagliola D;
AIDS; 2009 Apr; 23(7):817-24. PubMed ID: 19363330
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
Guillemi S; Harris M; Bondy GP; Ng F; Zhang W; Lima VD; Michaels CE; Belzberg A; Montaner JS
J Clin Densitom; 2010; 13(4):456-61. PubMed ID: 20663695
[TBL] [Abstract][Full Text] [Related]
11. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.
Calmy A; Fux CA; Norris R; Vallier N; Delhumeau C; Samaras K; Hesse K; Hirschel B; Cooper DA; Carr A
J Infect Dis; 2009 Dec; 200(11):1746-54. PubMed ID: 19874178
[TBL] [Abstract][Full Text] [Related]
12. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
13. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
14. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
16. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
17. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
Mitra D; Elvins DM; Collins AJ
J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of osteoporosis in Thai men.
Pongchaiyakul C; Apinyanurag C; Soontrapa S; Soontrapa S; Pongchaiyakul C; Nguyen TV; Rajatanavin R
J Med Assoc Thai; 2006 Feb; 89(2):160-9. PubMed ID: 16579001
[TBL] [Abstract][Full Text] [Related]
19. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density of the spine and femur in a group of healthy Moroccan men.
El Maghraoui A; Ghazi M; Gassim S; Mounach A; Ghozlani I; Nouijai A; Achemlal L; Bezza A; Dehhaoui M
Bone; 2009 May; 44(5):965-9. PubMed ID: 19168162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]